Clinics Collections: COVID-19 draws from Elsevier’s robust Clinics Review Articles database to provide multidisciplinary teams, including pediatricians, primary care physicians, and cardiologists, with practical clinical advice and insights from the COVID-19 pandemic and its impact across individual specialties.
Clinics Collections: COVID-19 guides readers on how to apply current best practices in the diagnosis and treatment of COVID-19 and associated comorbidities to everyday practice to help overcome challenges and complications, keep up with new and advanced treatment methods, and improve patient outcomes.
1. Cover image - p. i 2. Title page - p. ii 3. Table of Contents - p. ii 4. Contributors - p. iii 5. Preface - p. xvii 6. Pediatric Heart Disease - p. xvii 7. Congenital Heart Disease - p. 1 8. Pediatric Hypertension - p. 17 9. Preparticipation Cardiac Evaluation from the Pediatric Perspective - p. 29 10. The Risk of Sudden Unexpected Cardiac Death in Children: Epidemiology, Clinical Causes, and Prevention - p. 49 11. Adult Heart Disease - p. 61 12. Assessment of Cardiovascular Disease Risk: A 2022 Update - p. 63 13. Race and Modifiable Factors Influencing Cardiovascular Disease - p. 91 14. Cardiovascular Disease in Older Women - p. 101 15. Drug Interactions: What Are Important Drug Interactions for the Most Commonly Used Medications in Preventive Cardiology? - p. 117 16. Heart-Healthy Diets and the Cardiometabolic Jackpot - p. 129 17. The Role of Physical Activity and Exercise in Preventive Cardiology - p. 143 18. Management of Coronary Artery Disease - p. 153 19. Approach to the Patient with a Murmur - p. 169 20. Medical Management of Peripheral Artery Disease - p. 181 21. The Effects of Testosterone Treatment on Cardiovascular Health - p. 197 22. Obstructive Sleep Apnea and Cardiovascular Disease - p. 211 23. Management of Dyslipidemia in Endocrine Diseases - p. 223 24. Role of Lipid Management in Women’s Health Preventive Care - p. 237 25. New and Emerging Therapies for Dyslipidemia - p. 257 26. LDL Cholesterol—How Low Can We Go? - p. 277 27. High-Density Lipoprotein and Cardiovascular Disease—Where do We Stand? - p. 287 28. Current Status of Pharmacologic and Nonpharmacologic Therapy in Heart Failure with Preserved Ejection Fraction - p. 303 29. Telehealth in Heart Failure - p. 329 30. Hypertension and Heart Failure: Prevention, Targets, and Treatment - p. 341 31. Atrial Fibrillation and Heart Failure: Epidemiology, Pathophysiology, Prognosis, and Management - p. 351 32. Atrial Fibrillation in Valvular Heart Disease - p. 375 33. The Cardiorenal Syndrome in Heart Failure - p. 389
Clinics Collections: COVID-19 draws from Elsevier’s robust Clinics Review Articles database to provide multidisciplinary teams, including pediatricians, primary care physicians, and cardiologists, with practical clinical advice and insights from the COVID-19 pandemic and its impact across individual specialties.
Clinics Collections: COVID-19 guides readers on how to apply current best practices in the diagnosis and treatment of COVID-19 and associated comorbidities to everyday practice to help overcome challenges and complications, keep up with new and advanced treatment methods, and improve patient outcomes.
1. Cover image - p. i 2. Title page - p. ii 3. Table of Contents - p. ii 4. Contributors - p. iii 5. Preface - p. xvii 6. Pediatric Heart Disease - p. xvii 7. Congenital Heart Disease - p. 1 8. Pediatric Hypertension - p. 17 9. Preparticipation Cardiac Evaluation from the Pediatric Perspective - p. 29 10. The Risk of Sudden Unexpected Cardiac Death in Children: Epidemiology, Clinical Causes, and Prevention - p. 49 11. Adult Heart Disease - p. 61 12. Assessment of Cardiovascular Disease Risk: A 2022 Update - p. 63 13. Race and Modifiable Factors Influencing Cardiovascular Disease - p. 91 14. Cardiovascular Disease in Older Women - p. 101 15. Drug Interactions: What Are Important Drug Interactions for the Most Commonly Used Medications in Preventive Cardiology? - p. 117 16. Heart-Healthy Diets and the Cardiometabolic Jackpot - p. 129 17. The Role of Physical Activity and Exercise in Preventive Cardiology - p. 143 18. Management of Coronary Artery Disease - p. 153 19. Approach to the Patient with a Murmur - p. 169 20. Medical Management of Peripheral Artery Disease - p. 181 21. The Effects of Testosterone Treatment on Cardiovascular Health - p. 197 22. Obstructive Sleep Apnea and Cardiovascular Disease - p. 211 23. Management of Dyslipidemia in Endocrine Diseases - p. 223 24. Role of Lipid Management in Women’s Health Preventive Care - p. 237 25. New and Emerging Therapies for Dyslipidemia - p. 257 26. LDL Cholesterol—How Low Can We Go? - p. 277 27. High-Density Lipoprotein and Cardiovascular Disease—Where do We Stand? - p. 287 28. Current Status of Pharmacologic and Nonpharmacologic Therapy in Heart Failure with Preserved Ejection Fraction - p. 303 29. Telehealth in Heart Failure - p. 329 30. Hypertension and Heart Failure: Prevention, Targets, and Treatment - p. 341 31. Atrial Fibrillation and Heart Failure: Epidemiology, Pathophysiology, Prognosis, and Management - p. 351 32. Atrial Fibrillation in Valvular Heart Disease - p. 375 33. The Cardiorenal Syndrome in Heart Failure - p. 389
